Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions in retinal disease research and clinical trials, particularly those with expertise in neovascular AMD and PCV, conduct large-scale multicenter trials and have strong retinal imaging and therapeutic development programs. These centers often collaborate internationally and have extensive experience with anti-VEGF and novel biologic therapies.
-
#1
National Eye Institute (NEI), National Institutes of Health
Bethesda, MD
NEI leads in retinal disease research with extensive clinical trial infrastructure and pioneering work in AMD and PCV pathophysiology and treatment development.
-
#2
Singapore National Eye Centre (SNEC)
Singapore, N/A
SNEC is a leading Asian center specializing in retinal diseases with a strong focus on PCV, conducting pivotal clinical trials and contributing to understanding ethnic variations in AMD.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for retinal disease research and clinical trials, including novel therapies for AMD and PCV, with expertise in advanced retinal imaging and treatment protocols.
-
#4
The University of Tokyo Hospital, Department of Ophthalmology
Tokyo, N/A
A premier Japanese institution with significant contributions to PCV research and clinical management, including participation in Asian multicenter trials and development of treatment guidelines.
-
#5
Hong Kong Eye Hospital, Retina and Macula Centre
Hong Kong, N/A
Led by Dr. Timothy Lai, this center is directly involved in the SALWEEN study and specializes in PCV treatment and research in Asian populations, focusing on novel therapeutic durability and outcomes.